US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Health in Tech

1.00

-0.0200-1.96%

Post-market: 0.9900-0.0100-1.00%19:32 EDT

Volume:66.80K

Turnover:67.75K

Market Cap:65.53M

PE:-15.31

High:1.03

Open:0.9906

Low:0.9600

Close:1.02

52wk High:4.02

52wk Low:0.8501

Shares:65.53M

Float Shares:20.19M

Volume Ratio:0.43

T/O Rate:0.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0653

EPS(LYR):0.0200

ROE:-21.91%

ROA:-12.72%

PB:3.35

PE(LYR):50.00

Loading ...

Overview Company News Filings

Health In Tech price target lowered to $3 from $4 at Maxim

Maxim Group Sticks to Their Buy Rating for Health In Tech, Inc. Class A (HIT)

Health in Tech Q2 FY26 Net Loss Widens to $2.5 Million; Revenue Falls to $8.1 Million

Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate

Benzinga Earnings

Health in Tech - Reaffirms Full-Year 2026 Revenue Guidance of $45 Mln to $50 Mln

THOMSON REUTERS

Press Release: Health in Tech Reports Second Quarter 2026 Financial Results

Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process

Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Health in Tech to Report Q2 2026 Results, Host Earnings Call

Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview

Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress

AJJ Medtech sets governance framework for HIT-1 humanoid eldercare platform

Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Health In Tech Added to Russell Microcap Index

MT Newswires Live

Health In Tech added as member of Russell Microcap Index

Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress

Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease

Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/HIT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"HIT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","market":"US","secType":"STK","nameCN":"Health in Tech","latestPrice":1,"timestamp":1787342400000,"preClose":1.02,"halted":0,"volume":66798,"hourTrading":{"tag":"盘后","latestPrice":0.99,"preClose":1,"latestTime":"19:32 EDT","volume":108,"amount":106.99,"timestamp":1787355151087,"change":-0.01,"changeRate":-0.01,"amplitude":0.01},"delay":0,"changeRate":-0.01960784313725492,"floatShares":20192076,"shares":65529600,"eps":-0.0653,"marketStatus":"Market Closed","change":-0.02,"latestTime":"08-21 16:00:00 EDT","open":0.9906,"high":1.03,"low":0.96,"amount":67751.441253,"amplitude":0.068627,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0653,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1734930000000,"exchange":"NASDAQ","adjPreClose":1.02,"postHourTrading":{"tag":"盘后","latestPrice":0.99,"preClose":1,"latestTime":"19:32 EDT","volume":108,"amount":106.99,"timestamp":1787355151087,"change":-0.01,"changeRate":-0.01,"amplitude":0.01},"volumeRatio":0.43019935330221354},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HIT\",,,,,undefined,":{"symbol":"HIT","floatShares":20192076,"roa":"-12.72%","roe":"-21.91%","lyrEps":0.02,"volumeRatio":0.43019935330221354,"shares":65529600,"dividePrice":0,"high":1.03,"amplitude":0.068627,"preClose":1.02,"low":0.96,"week52Low":0.8501,"pbRate":"3.35","psRate":"2.00","week52High":4.02,"institutionHeld":0,"latestPrice":1,"eps":-0.0653,"divideRate":0,"volume":66798,"delay":0,"ttmEps":-0.0653,"open":0.9906,"prevYearClose":1.59,"prevWeekClose":1.005,"prevMonthClose":1.11,"prevQuarterClose":1.01,"fiveDayClose":1.005,"twentyDayClose":1.06,"sixtyDayClose":0.9347},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HIT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"HIT","fiscalQuarterEnding":"2026/06","expectedEps":-0.03,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2026-05-13","symbol":"HIT","fiscalQuarterEnding":"2026/03","expectedEps":-0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2026-03-25","symbol":"HIT","fiscalQuarterEnding":"2025/12","expectedEps":-0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.01},{"market":"US","date":"2025-04-14","symbol":"HIT","fiscalQuarterEnding":"2025/03","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1744603200000,"reportTimeType":"post","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HIT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HIT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1778817600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HIT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HIT","date":"2026-08-21","current":-15.313936,"percent":0.152174,"low":-99.750333,"twenty":31.714084,"median":58.601643,"eighty":127.348043,"high":221.999544,"avg":60.236865,"sd":77.066919,"marketCap":66845351},"quantilePoints":[{"date":"2024-12-27","current":157.125683,"twenty":141.889253,"median":160.399135,"eighty":163.672587,"marketCap":285486210},{"date":"2025-01-03","current":155.340164,"twenty":156.054372,"median":159.431979,"eighty":163.196448,"marketCap":282242048},{"date":"2025-01-10","current":163.077413,"twenty":154.387887,"median":159.134392,"eighty":162.958378,"marketCap":296300081},{"date":"2025-01-17","current":169.029144,"twenty":154.625956,"median":159.506375,"eighty":163.672587,"marketCap":307113953},{"date":"2025-01-24","current":153.257058,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":278457193},{"date":"2025-01-31","current":183.90847,"twenty":154.447404,"median":161.887067,"eighty":169.624317,"marketCap":334148632},{"date":"2025-02-07","current":158.018442,"twenty":154.447404,"median":161.291894,"eighty":169.029144,"marketCap":287108290},{"date":"2025-02-14","current":176.766393,"twenty":155.340164,"median":162.779827,"eighty":171.409836,"marketCap":321171986},{"date":"2025-02-21","current":200.275728,"twenty":156.768579,"median":163.672587,"eighty":173.909563,"marketCap":363886779},{"date":"2025-02-28","current":207.417805,"twenty":157.83989,"median":165.458105,"eighty":181.765847,"marketCap":376863425},{"date":"2025-03-07","current":212.774362,"twenty":158.73265,"median":167.690004,"eighty":197.061793,"marketCap":386595909},{"date":"2025-03-14","current":32.734517,"twenty":157.83989,"median":169.029144,"eighty":199.323452,"marketCap":59476293},{"date":"2025-03-21","current":56.458248,"twenty":154.030783,"median":165.606898,"eighty":197.656967,"marketCap":37853957},{"date":"2025-03-28","current":55.854885,"twenty":145.69836,"median":163.672587,"eighty":197.061793,"marketCap":37449416},{"date":"2025-04-04","current":54.649326,"twenty":57.938837,"median":162.779827,"eighty":197.002276,"marketCap":36641116},{"date":"2025-04-11","current":52.572179,"twenty":55.748991,"median":161.291894,"eighty":191.050546,"marketCap":35248437},{"date":"2025-04-17","current":34.087191,"twenty":54.660513,"median":159.506375,"eighty":186.170128,"marketCap":36423288},{"date":"2025-04-25","current":33.769958,"twenty":52.396232,"median":159.134392,"eighty":182.301503,"marketCap":36084314},{"date":"2025-05-02","current":31.160461,"twenty":45.578303,"median":157.125683,"eighty":179.087568,"marketCap":33295981},{"date":"2025-05-09","current":39.930417,"twenty":35.548508,"median":154.298611,"eighty":177.659153,"marketCap":42666968},{"date":"2025-05-16","current":34.281623,"twenty":35.548508,"median":153.257058,"eighty":177.123497,"marketCap":36631046},{"date":"2025-05-23","current":33.258292,"twenty":34.731889,"median":135.699453,"eighty":174.62377,"marketCap":35537582},{"date":"2025-05-30","current":33.427142,"twenty":34.164964,"median":62.92533,"eighty":173.07632,"marketCap":35718004},{"date":"2025-06-06","current":32.245193,"twenty":33.613388,"median":57.019717,"eighty":172.302595,"marketCap":34455053},{"date":"2025-06-13","current":30.699962,"twenty":33.084325,"median":56.156566,"eighty":171.409836,"marketCap":32803922},{"date":"2025-06-20","current":30.699962,"twenty":32.521493,"median":55.626806,"eighty":171.290801,"marketCap":32803922},{"date":"2025-06-27","current":40.953749,"twenty":32.521493,"median":54.649326,"eighty":170.576594,"marketCap":43760432},{"date":"2025-07-03","current":43.537662,"twenty":32.644293,"median":53.403037,"eighty":169.624317,"marketCap":46521429},{"date":"2025-07-11","current":56.794929,"twenty":32.734517,"median":52.352245,"eighty":169.029144,"marketCap":60687256},{"date":"2025-07-18","current":61.399923,"twenty":33.002459,"median":53.724933,"eighty":166.350865,"marketCap":65607844},{"date":"2025-07-25","current":80.355571,"twenty":33.207125,"median":54.437195,"eighty":165.755692,"marketCap":109376548},{"date":"2025-08-01","current":85.740222,"twenty":33.258292,"median":55.423164,"eighty":165.458105,"marketCap":116705904},{"date":"2025-08-08","current":95.681118,"twenty":33.427142,"median":55.842666,"eighty":164.267759,"marketCap":130237023},{"date":"2025-08-15","current":134.225003,"twenty":33.509008,"median":56.458248,"eighty":163.672587,"marketCap":182701302},{"date":"2025-08-22","current":141.681948,"twenty":33.769958,"median":56.907323,"eighty":163.672587,"marketCap":192851375},{"date":"2025-08-29","current":115.996916,"twenty":33.826241,"median":58.296911,"eighty":163.077413,"marketCap":157890014},{"date":"2025-09-05","current":116.411191,"twenty":33.871267,"median":61.399923,"eighty":162.601275,"marketCap":158453907},{"date":"2025-09-12","current":115.582641,"twenty":33.960297,"median":65.505359,"eighty":162.006102,"marketCap":157326121},{"date":"2025-09-19","current":146.238969,"twenty":34.065701,"median":68.343655,"eighty":161.410929,"marketCap":199054197},{"date":"2025-09-26","current":136.296377,"twenty":34.242737,"median":75.592225,"eighty":161.291894,"marketCap":185520767},{"date":"2025-10-03","current":145.41042,"twenty":34.400329,"median":82.840795,"eighty":159.863479,"marketCap":197926411},{"date":"2025-10-10","current":142.510497,"twenty":34.597833,"median":90.503568,"eighty":159.506375,"marketCap":193979161},{"date":"2025-10-17","current":142.096223,"twenty":34.762589,"median":102.722585,"eighty":159.387341,"marketCap":193415268},{"date":"2025-10-24","current":124.28241,"twenty":34.80557,"median":108.747109,"eighty":159.000478,"marketCap":169167873},{"date":"2025-10-31","current":108.125697,"twenty":35.001026,"median":110.197071,"eighty":158.196994,"marketCap":147176049},{"date":"2025-11-07","current":115.996916,"twenty":35.126896,"median":111.232757,"eighty":157.304235,"marketCap":157890014},{"date":"2025-11-14","current":65.041128,"twenty":35.682565,"median":110.611345,"eighty":156.370386,"marketCap":88531186},{"date":"2025-11-21","current":49.494631,"twenty":36.438807,"median":109.575659,"eighty":155.508444,"marketCap":71136010},{"date":"2025-11-28","current":60.185471,"twenty":37.969712,"median":108.125697,"eighty":154.804508,"marketCap":86501388},{"date":"2025-12-05","current":50.286545,"twenty":39.123499,"median":102.722585,"eighty":154.268852,"marketCap":72274186},{"date":"2025-12-12","current":41.971447,"twenty":39.670818,"median":90.503568,"eighty":153.792714,"marketCap":60323336},{"date":"2025-12-19","current":53.850158,"twenty":40.532136,"median":85.740222,"eighty":153.376093,"marketCap":77395978},{"date":"2025-12-26","current":60.185471,"twenty":40.941469,"median":80.355571,"eighty":152.899954,"marketCap":86501388},{"date":"2026-01-02","current":62.95717,"twenty":41.131809,"median":75.81227,"eighty":152.364298,"marketCap":90485004},{"date":"2026-01-09","current":63.353127,"twenty":41.869528,"median":71.272268,"eighty":151.636362,"marketCap":91054092},{"date":"2026-01-16","current":55.433987,"twenty":41.971447,"median":68.343655,"eighty":148.393197,"marketCap":79672331},{"date":"2026-01-23","current":58.601643,"twenty":41.971447,"median":67.881746,"eighty":147.067519,"marketCap":84225035},{"date":"2026-01-30","current":47.118888,"twenty":41.971447,"median":66.520784,"eighty":146.238969,"marketCap":67721481},{"date":"2026-02-06","current":39.591745,"twenty":41.971447,"median":65.041128,"eighty":145.824695,"marketCap":56903117},{"date":"2026-02-13","current":42.763361,"twenty":41.971447,"median":63.551106,"eighty":145.824695,"marketCap":61461512},{"date":"2026-02-20","current":42.458474,"twenty":41.971447,"median":63.24105,"eighty":145.493275,"marketCap":61023314},{"date":"2026-02-27","current":53.454201,"twenty":42.254301,"median":62.721688,"eighty":145.079,"marketCap":76826890},{"date":"2026-03-06","current":66.520784,"twenty":42.431782,"median":62.443472,"eighty":144.664725,"marketCap":95606797},{"date":"2026-03-13","current":76.815667,"twenty":42.702384,"median":63.128972,"eighty":143.919031,"marketCap":110403087},{"date":"2026-03-20","current":79.19141,"twenty":42.763361,"median":63.551106,"eighty":143.090481,"marketCap":113817616},{"date":"2026-03-27","current":72.649053,"twenty":42.763361,"median":64.540999,"eighty":142.593352,"marketCap":92906660},{"date":"2026-04-02","current":72.794568,"twenty":42.763361,"median":65.041128,"eighty":142.510497,"marketCap":93092751},{"date":"2026-04-10","current":71.769293,"twenty":42.834982,"median":66.322806,"eighty":142.261933,"marketCap":91781586},{"date":"2026-04-17","current":73.819844,"twenty":42.993249,"median":67.312698,"eighty":141.847658,"marketCap":94403917},{"date":"2026-04-24","current":77.408308,"twenty":43.122362,"median":67.688423,"eighty":141.681948,"marketCap":98992996},{"date":"2026-05-01","current":74.332482,"twenty":43.386324,"median":67.929451,"eighty":140.936253,"marketCap":95059500},{"date":"2026-05-08","current":80.448884,"twenty":43.537662,"median":68.725663,"eighty":139.941994,"marketCap":102881412},{"date":"2026-05-15","current":-99.750333,"twenty":43.537662,"median":68.80861,"eighty":139.113444,"marketCap":80601361},{"date":"2026-05-22","current":-74.812749,"twenty":42.834982,"median":68.518561,"eighty":138.284895,"marketCap":60451020},{"date":"2026-05-29","current":-79.273129,"twenty":42.763361,"median":67.905598,"eighty":137.622056,"marketCap":64055146},{"date":"2026-06-05","current":-81.097832,"twenty":41.971447,"median":67.66819,"eighty":136.959216,"marketCap":65529562},{"date":"2026-06-12","current":-85.963701,"twenty":41.682913,"median":67.11472,"eighty":136.544941,"marketCap":69461335},{"date":"2026-06-18","current":-85.963701,"twenty":40.13099,"median":66.322806,"eighty":136.213522,"marketCap":69461335},{"date":"2026-06-26","current":-78.656787,"twenty":37.052807,"median":65.041128,"eighty":135.799247,"marketCap":63557122},{"date":"2026-07-02","current":-85.963701,"twenty":35.049122,"median":64.353376,"eighty":135.467827,"marketCap":69461335},{"date":"2026-07-10","current":-88.396636,"twenty":34.430006,"median":63.551106,"eighty":134.225003,"marketCap":71427222},{"date":"2026-07-17","current":-86.774679,"twenty":33.882524,"median":63.128972,"eighty":134.225003,"marketCap":70116631},{"date":"2026-07-24","current":-85.98016,"twenty":33.427142,"median":62.443472,"eighty":132.982179,"marketCap":69474635},{"date":"2026-07-31","current":-84.357893,"twenty":32.948871,"median":61.429682,"eighty":132.982179,"marketCap":68163793},{"date":"2026-08-07","current":-90.846963,"twenty":32.464186,"median":60.185471,"eighty":132.982179,"marketCap":73407162},{"date":"2026-08-14","current":-85.98016,"twenty":32.12751,"median":60.185471,"eighty":131.6565,"marketCap":69474635},{"date":"2026-08-21","current":-16.924219,"twenty":31.714084,"median":58.601643,"eighty":127.348043,"marketCap":66845351}],"updateTime":1787479299346},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HIT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659172071","title":"Health In Tech price target lowered to $3 from $4 at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2659172071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659172071?lang=en_us&edition=fundamental","pubTime":"2026-08-16 21:21","pubTimestamp":1786886504,"startTime":"0","endTime":"0","summary":"Maxim lowered the firm’s price target on Health In Tech (HIT) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model af...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-price-target-lowered-to-3-from-4-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-price-target-lowered-to-3-from-4-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315144","title":"Maxim Group Sticks to Their Buy Rating for Health In Tech, Inc. Class A (HIT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315144?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:55","pubTimestamp":1786712157,"startTime":"0","endTime":"0","summary":"In a report released today, Allen Klee from Maxim Group reiterated a Buy rating on Health In Tech, Inc. Class A, with a price target of $3.00. Klee...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-health-in-tech-inc-class-a-hit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/maxim-group-sticks-to-their-buy-rating-for-health-in-tech-inc-class-a-hit-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659709167","title":"Health in Tech Q2 FY26 Net Loss Widens to $2.5 Million; Revenue Falls to $8.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659709167","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659709167?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:37","pubTimestamp":1786653463,"startTime":"0","endTime":"0","summary":"Health In Tech Q2 FY26 net loss widens to $2.5 million; revenue falls to $8.1 millionHealth In Tech Q2 revenue fell to $8.1 million from $9.3 million a year earlier.Net results swung to a $2.5 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL6CGJty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659316746","title":"Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2659316746","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659316746?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:31","pubTimestamp":1786653094,"startTime":"0","endTime":"0","summary":"Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 500 percent decrease over earnings of $0.01 per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61194685/health-tech-q2-eps-0-04-misses-0-03-estimate-sales-8-057m-beat-7-547m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659616709","title":"Health in Tech - Reaffirms Full-Year 2026 Revenue Guidance of $45 Mln to $50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2659616709","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659616709?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:30","pubTimestamp":1786653002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUA5CDRDP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659167229","title":"Press Release: Health in Tech Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659167229","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659167229?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:30","pubTimestamp":1786653000,"startTime":"0","endTime":"0","summary":"Contracted Revenue of $32.3 Million as of June 30, 2026Pipeline Revenue of $66.3 Million as of July 31, 2026Distribution Partners Grew 19.9% Year Over YearSTUART, Fla., Aug. 13, 2026 /PRNewswire/ -- Health In Tech, Inc.  , an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three and six months ended June 30, 2026.Second Quarter and First-Half 2026 Highlights-- Distribution Partners, including brokers, third-party administrators.  and agencies, reached 933 as of June 30, 2026, an increase of. -- Q2 2026 Revenue was $8.1 million, compared with $9.3 million in Q2 2025.First-half 2026 revenue was $16.8 million, compared with $17.3 million in. -- Contracted Revenue1 totaled $32.3 million for first-half 2026, of which. $17.3 million was recognized as GAAP revenue in first-half 2026. The. remaining $14.0 million and $1.0 million are expected to be recognized as. GAAP revenue in second-half 2026 and in 2027, respectively.-- Pipeline Revenue2 was $","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAI","BK4561","BK4590","MDST","TNGY","BK4173","BK4581","ET","TPZ","ENFR","EMLP","BK4585","EIPI","UMI","AMLP","BK4588","BK4144","AMZA","HIT","MLPA","EIPX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659952921","title":"Cadrenal Therapeutics Reports Second Quarter 2026 Financial Results; Provides a Corporate Update on the Cardiac Acute Critical Care Franchise and the Strategic Partnering Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2659952921","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659952921?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:15","pubTimestamp":1786652100,"startTime":"0","endTime":"0","summary":"Late-breaking Phase 2 CAD-1005 data presented at ISTH support a late-stage portfolio organized around preoperative safety, orphan regulatory acceleration, and postoperative shieldingPONTE VEDRA, Fla.,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/13/3344960/0/en/cadrenal-therapeutics-reports-second-quarter-2026-financial-results-provides-a-corporate-update-on-the-cardiac-acute-critical-care-franchise-and-the-strategic-partnering-process.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","IE00B19Z4B17.USD","CACC","IE0031619046.USD","IE00B66KJ199.SGD","BK4166","BK4007","BK4134","BK4173","BK4139","IE00B7SZL793.SGD","HIT","LENZ","KD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658943723","title":"Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658943723","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658943723?lang=en_us&edition=fundamental","pubTime":"2026-08-12 04:33","pubTimestamp":1786480386,"startTime":"0","endTime":"0","summary":"Health In Tech Inc <HIT.OQ> expected to post a loss of2cents a share - Earnings PreviewHealth In Tech IncHIT.OQHIT.Ois expected to  show a fall in quarterly revenue when it reports  results on August ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL8N44823J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656230130","title":"Health in Tech to Report Q2 2026 Results, Host Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2656230130","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656230130?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787551,"startTime":"0","endTime":"0","summary":"Health In Tech to report Q2 2026 results, host earnings callHealth In Tech schedules second-quarter 2026 results release for Aug. 13, 2026, following the market close.Earnings conference call set for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL5KvTYb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656379102","title":"Cadrenal Therapeutics Solidifies Multi-Indication Strategy for CAD-1005 in Cardiac Acute Critical Care Following Competitor’s Phase 3 Discontinuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2656379102","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656379102?lang=en_us&edition=fundamental","pubTime":"2026-08-03 20:30","pubTimestamp":1785760200,"startTime":"0","endTime":"0","summary":"UrgentNeed for Novel Targets - Recent clinical failure of a competing mechanism highlights urgent need for novel upstream targets, such as 12-LOX, that are being studied to address the root causes of ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337506/0/en/Cadrenal-Therapeutics-Solidifies-Multi-Indication-Strategy-for-CAD-1005-in-Cardiac-Acute-Critical-Care-Following-Competitor-s-Phase-3-Discontinuation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4166","BK4173","KD","LENZ","IE00B19Z4B17.USD","BK4139","IE00BHPRN162.USD","LU0149725797.USD","IE00B66KJ199.SGD","CSA","IE00B7SZL793.SGD","BK4539","BK4007","CACC","HIT","IE0031619046.USD","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653277765","title":"Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277765","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277765?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635200,"startTime":"0","endTime":"0","summary":"Capital-efficient strategy focuses on differentiated therapies for cardiac pre- and post-operative critical care and orphan cardiovascular conditionsCompany is exploring development, licensing, and co","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/21/3330413/0/en/Cadrenal-Therapeutics-Launches-Partnering-Process-as-Its-Cardiac-Acute-Critical-Care-Assets-Advance-to-Transaction-Readiness-Following-Landmark-ISTH-Data-Presentation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","KD","BK4007","BK4139","LENZ","BK4183","ODD","BK4134","HIT","IE00B19Z4B17.USD","BK4211","IE00B66KJ199.SGD","BK4539","IE0031619046.USD","BK4173","LARK","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652013280","title":"Health in Tech Inc Expected to Post a Loss of 2 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2652013280","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652013280?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:27","pubTimestamp":1784320028,"startTime":"0","endTime":"0","summary":"Health In Tech Incexpected to post a loss of2cents a share - Earnings PreviewHealth In Tech IncHIT.OQHIT.Ois expected to  show a fall in quarterly revenue when it reports  results on July 20 (estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL8N43J1Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","HIT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651146031","title":"Cadrenal Therapeutics’ Late-Breaking Phase 2 Data Demonstrate Greater Than 25% Reduction in Thrombotic Events in HIT for First-in-Class 12-LOX Inhibitor CAD-1005 at ISTH 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2651146031","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651146031?lang=en_us&edition=fundamental","pubTime":"2026-07-13 21:00","pubTimestamp":1783947600,"startTime":"0","endTime":"0","summary":"Selected as one of three late-breakthrough abstracts: clinical trials and innovation in thrombosis, CAD-1005 took center stage before the global thrombosis community at the largest ISTH meeting in mor","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/13/3326228/0/en/Cadrenal-Therapeutics-Late-Breaking-Phase-2-Data-Demonstrate-Greater-Than-25-Reduction-in-Thrombotic-Events-in-HIT-for-First-in-Class-12-LOX-Inhibitor-CAD-1005-at-ISTH-2026-Congres.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","KD","BK4007","BK4139","LENZ","BK4081","BK4134","HIT","IE00B19Z4B17.USD","BK4539","IE0031619046.USD","BK4173","EMA","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612731","title":"AJJ Medtech sets governance framework for HIT-1 humanoid eldercare platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612731?lang=en_us&edition=fundamental","pubTime":"2026-07-13 08:02","pubTimestamp":1783900943,"startTime":"0","endTime":"0","summary":"AJJ Medtech Holdings Limited ( ($SG:584) ) just unveiled an update. AJJ Medtech Holdings has released a detailed public-facing Q&A to explain the A...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ajj-medtech-sets-governance-framework-for-hit-1-humanoid-eldercare-platform?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ajj-medtech-sets-governance-framework-for-hit-1-humanoid-eldercare-platform?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG","HIT","BK4173","BK4209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648593971","title":"Cadrenal Therapeutics Announces up to $8.8 Million Private Placement Priced At-The-Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2648593971","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648593971?lang=en_us&edition=fundamental","pubTime":"2026-07-01 08:00","pubTimestamp":1782864000,"startTime":"0","endTime":"0","summary":"$3 million upfront with up to approximately $5.8 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/01/3320268/0/en/Cadrenal-Therapeutics-Announces-up-to-8-8-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4134","IE00B66KJ199.SGD","LENZ","IE00B7SZL793.SGD","IE00B19Z4B17.USD","HIT","KD","BK4007","IE0031619046.USD","BK4173","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647737408","title":"Health In Tech Added to Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2647737408","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647737408?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:08","pubTimestamp":1782738539,"startTime":"0","endTime":"0","summary":"Health In Tech  said Monday it has been added as a member of the Russell Microcap Index, effective at the start of the trading session today.The addition comes as part of the annual Russell US indexes reconstitution, according to a statement.Shares of the company were down 4.9% in Monday premarket trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7057","HIT","BK4173","HIT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647373805","title":"Health In Tech added as member of Russell Microcap Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2647373805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647373805?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:10","pubTimestamp":1782727835,"startTime":"0","endTime":"0","summary":"Health In Tech (HIT) was added as a member of the Russell Microcap Index, effective when the U.S. market opens on June 29, as part of the 2026 Russ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-in-tech-added-as-member-of-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-in-tech-added-as-member-of-russell-microcap-index-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HIT","BK4173"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645818942","title":"Cadrenal Therapeutics Announces Selection of CAD-1005 Phase 2 Study for Late-Breaking Oral Presentation at ISTH 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2645818942","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645818942?lang=en_us&edition=fundamental","pubTime":"2026-06-24 20:00","pubTimestamp":1782302400,"startTime":"0","endTime":"0","summary":"Selection highlights the clinical value potential of Cadrenal’s first-in-class 12-lipoxygenase inhibitor for Heparin-Induced Thrombocytopenia (HIT) First-ever randomized, blinded, placebo-controlled t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/24/3316790/0/en/Cadrenal-Therapeutics-Announces-Selection-of-CAD-1005-Phase-2-Study-for-Late-Breaking-Oral-Presentation-at-ISTH-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","IE00B19Z4B17.USD","BK4134","BK4007","HIT","LENZ","BK4539","IE0031619046.USD","IE00B66KJ199.SGD","KD","BK4139","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644896240","title":"Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2644896240","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644896240?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:00","pubTimestamp":1781787600,"startTime":"0","endTime":"0","summary":"Company to present Phase 3-ready pipeline, 12-LOX platform, and pediatric rare-disease expansion to global pharmaceutical partners at the 2026 BIO International Convention in San Diego Kawasaki diseas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/18/3314211/0/en/Cadrenal-Therapeutics-to-File-for-FDA-Rare-Pediatric-Disease-Designation-for-Tecarfarin-in-Kawasaki-Disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","IE00B7SZL793.SGD","KD","BK4588","LABU","LENZ","BK4139","IE00B19Z4B17.USD","BK4007","HIT","BK4134","BK4539","BK4173","BK4585","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643205436","title":"Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Plan to Accelerate Pharma Partnering at Upcoming BIO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643205436","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643205436?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:30","pubTimestamp":1781526600,"startTime":"0","endTime":"0","summary":"New high-value indication for Phase 3-ready asset with data intended to support clinical development and strategic partnering discussionsAdditional billion-dollar target- Cardiac Surgery-Associated Ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311786/0/en/Cadrenal-Therapeutics-Advances-Multi-Indication-Strategy-for-CAD-1005-Launches-Phase-2a-Acute-Kidney-Injury-CSA-AKI-Clinical-Plan-to-Accelerate-Pharma-Partnering-at-Upcoming-BIO-20.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSA","BIO","AAQC","LU1169589451.USD","HIT","BK4183","BK4585","BK4139","LU1169590202.USD","IE0009354923.USD","BK4539","BK4588","BK4121","ODD","BK4212","LU0149725797.USD","BK4173","CPB","IE00BHPRN162.USD","BK4007","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}]}}